NEW YORK (GenomeWeb) – Cepheid's new CLIA-waived influenza test and multi-module instrument are intended for use at the point of care, putting them in competition with a handful of other systems in the rapid molecular diagnostic test space for flu.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.